Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider ....
Regulatory Filings
2022-06-30 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document contains detailed tabular data about share acquisitions and disposals, including dates, share counts, percentages of total equity share capital, names of promoters, and references to SEBI regulations related to substantial acquisition of shares and takeovers. This type of information aligns with notifications about changes in significant share ownership levels, typically reported under major shareholding notifications. The document is not a full financial report, earnings release, or management discussion, nor is it a regulatory announcement or proxy material. The presence of specific shareholding percentages and transaction types confirms it is a Major Shareholding Notification.
2022-06-18 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 90% confidence The document text primarily contains tabular data related to encumbered shares, promoter holdings, and events pertaining to encumbrance such as creation, release, and invocation of encumbrance. It references specific dates and names of promoters but does not include financial statements, earnings data, or detailed management discussion. The content focuses on shareholding details and encumbrance events, which are typically part of regulatory disclosures about shareholding and encumbrance status. The document length is short (2050 characters), and it does not appear to be a full report but rather a regulatory announcement or disclosure. Given the nature of the content and the absence of financial results or management commentary, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2022-06-18 English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved; ....
Regulatory Filings
2022-06-08 English
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure on Related Party Transaction ....
Regulatory Filings
2022-06-02 English
Related Party Transaction
Regulatory Filings
2022-06-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.